NCT02951793

Brief Summary

Investigators are seeking to determine the impact of recent alcohol, smoking or psychotropic drug use prior to intensive care unit (ICU) admission on incidence of delirium and sedation requirements. Study design: A prospective observational study, in a medical ICU of a tertiary university hospital. Methods: For all new ICU admissions, a 1-page questionnaire including Alcohol Use Disorders Identification Test (AUDIT-C), smoking history and prior medication use was given to the patient or closest family members. Delirium was assessed by trained ICU nurses using Intensive Care Delirium Screening Checklist and Richmond Agitation-Sedation Scale.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2016

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2016

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

October 11, 2016

Completed
21 days until next milestone

First Posted

Study publicly available on registry

November 1, 2016

Completed
6.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2022

Completed
Last Updated

August 20, 2021

Status Verified

August 1, 2021

Enrollment Period

6.8 years

First QC Date

October 11, 2016

Last Update Submit

August 18, 2021

Conditions

Keywords

intensive care unitdeliriumsubstance withdrawal

Outcome Measures

Primary Outcomes (1)

  • Delirium during ICU stay

    From date of ICU admission until the date of ICU discharge, whichever came first, assessed up to 3 months

Secondary Outcomes (5)

  • ICU length of stay

    From date of ICU admission until the date of first documented discharge from ICU or death, whichever came first, assessed up to 3 months

  • Mortality

    From date of ICU admission until the date of death, assessed up to 3 months

  • Maximal doses of dexmedetomidine

    From date of ICU admission until the date of first documented discharge from ICU or death, whichever came first, assessed up to 3 months

  • Cumulative dose of dexmedetomidine

    From date of ICU admission until the date of first documented discharge from ICU or death, whichever came first, assessed up to 3 months

  • Cumulative dose of midazolam

    From date of ICU admission until the date of first documented discharge from ICU or death, whichever came first, assessed up to 3 months

Study Arms (6)

AUDIT-C > 4

Significant alcohol use within 1 year prior to ICU admission (AUDIT-C\>4)

Other: AUDIT-C

AUDIT-C <=4

No significant alcohol use within 1 year prior to ICU admission (AUDIT-C: equal or less than 4)

Other: AUDIT-C

Smoking history positive last year

Who smoke cigarette within 1-year prior to ICU admission

Other: Smoking history

Smoking history negative last year

Who did not smoke cigarette within 1-year prior to ICU admission

Other: Smoking history

Prior psychotropic medication use - yes

Who used psychotropic medication within 1-year prior to ICU admission

Other: Prior psychotropic medication use

Prior psychotropic medication use - no

Who did not use psychotropic medication within 1-year prior to ICU admission

Other: Prior psychotropic medication use

Interventions

AUDIT-COTHER

Patients or their proxy/closest family member(s) undergo a comprehensive questionnaire including AUDIT-C about his/her alcohol behavior during last year and will be categorized into two groups: Those with AUDIT-C\>4 versus AUDIT-C of 4 or below.

Also known as: Alcohol Use Disorders Identification Test
AUDIT-C <=4AUDIT-C > 4

Patients or their proxy/closest family member(s) undergo a comprehensive questionnaire including smoking history during last year and will be categorized into two groups: Current smoker versus ex- or never smoker (we also recorded smoking pack-years to distinguish heavy smokers)

Smoking history negative last yearSmoking history positive last year

Patients or their proxy/closest family member(s) undergo a comprehensive questionnaire including psychotropic medication use prior admission to ICU and will be categorized into two groups: Those who use psychotropic medication versus those who do not use psychotropic medication.

Prior psychotropic medication use - noPrior psychotropic medication use - yes

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

For all new ICU admissions above age of 18 years, except for those who fulfill exclusion criteria

You may qualify if:

  • Patients who are older than 18 years of age
  • New patients admitted to medical ICU for the 1st time during their stay in hospital

You may not qualify if:

  • Had history of stroke or other primary neurologic disease
  • GCS ≤ 8 prior to ICU admission
  • Transferred from other ICU (except for emergency ICU stay which is limited to less than 36 hours)
  • Not registered within 24 hours after admission
  • Refused to participate
  • If comatous state persists
  • Delirium assessment is not possible due to newly developed neurologic disease, such as cerebral infarction
  • Medical ICU stay less than 24 hours
  • Readmission to medical ICU

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Seoul National University Hospital

Seoul, 110744, South Korea

Location

MeSH Terms

Conditions

Substance Withdrawal SyndromeDelirium

Interventions

Ethanol

Condition Hierarchy (Ancestors)

Substance-Related DisordersChemically-Induced DisordersMental DisordersConfusionNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsNeurocognitive Disorders

Intervention Hierarchy (Ancestors)

AlcoholsOrganic Chemicals

Study Officials

  • Jinwoo Lee, Professor

    Seoul National University Hospital

    STUDY CHAIR
  • Jungsil Lee, M.D.

    Seoul National University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

October 11, 2016

First Posted

November 1, 2016

Study Start

March 1, 2016

Primary Completion

December 1, 2022

Study Completion

December 1, 2022

Last Updated

August 20, 2021

Record last verified: 2021-08

Data Sharing

IPD Sharing
Will not share

Locations